All Stories

  1. The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways
  2. The next step: mechanisms driving adrenocortical carcinoma metastasis
  3. Small non-coding RNAs in endocrinology
  4. VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma
  5. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma
  6. NR5A1 (nuclear receptor subfamily 5, group A, member 1)
  7. The role of p27 in pheochromocytoma development
  8. Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma
  9. The ER-mitochondria couple: In life and death from steroidogenesis to tumorigenesis
  10. Modeling Fragile X syndrome in neurogenesis: An unexpected phenotype and a novel tool for future therapies
  11. ER-mitochondria contacts find their FATE
  12. FATE1 antagonizes calcium‐ and drug‐induced apoptosis by uncoupling ER and mitochondria
  13. Impact of ACTH Signaling on Transcriptional Regulation of Steroidogenic Genes
  14. Local Control of Aldosterone Production and Primary Aldosteronism
  15. Special issue on animal models in endocrine neoplasia
  16. 5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications
  17. Mitotane Revisited: A New Target for an Old Drug
  18. DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma
  19. Natural paniceins from mediterranean sponge inhibit the multidrug resistance activity of patched and increase chemotherapy efficiency on melanoma cells
  20. How genomic studies have improved our understanding of the mechanisms of transcriptional regulation by NR5A nuclear receptors
  21. Role of steroidogenic factor-1 in the pathogenesis of adrenocortical tumours
  22. Pediatric Adrenocortical Tumors: What They Can Tell Us on Adrenal Development and Comparison with Adult Adrenal Tumors
  23. Genome-Wide Paternal Uniparental Disomy as a Cause of Beckwith-Wiedemann Syndrome Associated with Recurrent Virilizing Adrenocortical Tumors
  24. Two-pore domain potassium channels in the adrenal cortex
  25. Vanin-1 Inactivation Antagonizes the Development of Adrenocortical Neoplasia inSf-1Transgenic Mice
  26. Role of Orphan Nuclear Receptor DAX-1/NR0B1 in Development, Physiology, and Disease
  27. Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma
  28. Genomic Analysis of Sexual Dimorphism of Gene Expression in the Mouse Adrenal Gland
  29. Severe Hyperaldosteronism in Neonatal Task3 Potassium Channel Knockout Mice Is Associated With Activation of the Intraadrenal Renin-Angiotensin System
  30. Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation
  31. Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates
  32. Efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 in a preclinical model of adrenocortical carcinoma
  33. Task3 Potassium Channel Gene Invalidation Causes Low Renin and Salt-Sensitive Arterial Hypertension
  34. Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex
  35. SNP Array Profiling of Childhood Adrenocortical Tumors Reveals Distinct Pathways of Tumorigenesis and Highlights Candidate Driver Genes
  36. Identity by Descent Mapping of Founder Mutations in Cancer Using High-Resolution Tumor SNP Data
  37. Adrenal Cancer: Scientific Advances
  38. Dysregulation of microRNAs in adrenocortical tumors
  39. Adrenal Cancer: Clinical Advances
  40. Aldosterone-Producing Adenoma Formation in the Adrenal Cortex Involves Expression of Stem/Progenitor Cell Markers
  41. Genetics and genomics of childhood adrenocortical tumors
  42. Increased Incidence of Choroid Plexus Carcinoma Due to the Germline TP53 R337H Mutation in Southern Brazil
  43. The Wnt/beta-catenin pathway in adrenocortical development and cancer
  44. Gonadotropin-Dependent Precocious Puberty in a Patient with X-Linked Adrenal Hypoplasia Congenita Caused by a Novel DAX-1 Mutation
  45. Adrenal cortex ontogenesis
  46. Targeting DAX-1 in embryonic stem cells and cancer
  47. Identification and Characterization of Steroidogenic Factor-1 Inverse Agonists
  48. Dax-1 Knockdown in Mouse Embryonic Stem Cells Induces Loss of Pluripotency and Multilineage Differentiation
  49. Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists
  50. Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists
  51. Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists
  52. Differential Effects of High and Low Steroidogenic Factor-1 Expression on CYP11B2 Expression and Aldosterone Production in Adrenocortical Cells
  53. FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure
  54. The T cell factor/β-Catenin Antagonist PKF115–584 Inhibits Proliferation of Adrenocortical Carcinoma Cells
  55. Increased Steroidogenic Factor-1 Dosage Triggers Adrenocortical Cell Proliferation and Cancer
  56. Partial defects in transcriptional activity of two novel DAX-1 mutations in childhood-onset adrenal hypoplasia congenita
  57. Transcriptional Regulation of the Glucose-6-phosphatase Gene by cAMP/Vasoactive Intestinal Peptide in the Intestine
  58. SF-1 overexpression in childhood adrenocortical tumours
  59. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors
  60. Extracellular Matrix and Hormones Modulate DAX-1 Localization in the Human Fetal Adrenal Gland
  61. Amplification of the Steroidogenic Factor 1 Gene in Childhood Adrenocortical Tumors
  62. Heat Shock Affects Trafficking of DAX-1 by Inducing Its Rapid and Reversible Cytoplasmic Localization
  63. DAX-1, an Unusual Orphan Receptor at the Crossroads of Steroidogenic Function and Sexual Differentiation
  64. Regulation of Niemann-Pick C1 Gene Expression by the 3′5′-Cyclic Adenosine Monophosphate Pathway in Steroidogenic Cells
  65. DAX-1
  66. Regulation of Steroidogenesis and the Steroidogenic Acute Regulatory Protein by a Member of the cAMP Response-Element Binding Protein Family
  67. Heat Shock Interferes with Steroidogenesis by Reducing Transcription of the Steroidogenic Acute Regulatory Protein Gene
  68. DAX-1 and the adrenal cortex
  69. DAX-1 Blocks Steroid Production at Multiple Levels1
  70. A Transcriptional Silencing Domain in DAX-1 Whose Mutation Causes Adrenal Hypoplasia Congenita
  71. Coupling Signal Transduction to Transcription: The Nuclear Response to cAMP
  72. 6 Coupling transcription to signaling pathways
  73. DNA ploidy analysis of squamous cell carcinomas of the oral and maxillofacial region
  74. CREM
  75. CREM, a master-switch in the nuclear response to cAMP signaling
  76. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita
  77. Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor
  78. Nuclear response to cyclic AMP: central role of transcription factor CREM (cyclic-AMP-responsive-element modulator)
  79. In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression
  80. Serum markers of immune activation and liver allograft rejection